Wednesday, March 29, 2017
ARMO BioSciences Announces First Patient Dosed in Pivotal Phase 3 Trial of Immunotherapy AM0010 for Advanced Pancreatic Cancer
REDWOOD CITY, Calif., March 29, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a clinical-stage immuno-oncology company, announced that the first patient has been dosed in the Company's international Phase 3 pivotal clinical trial to evaluate its lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) in co.....

GW Pharmaceuticals Announces Epidiolex® Receives Orphan Drug Designation from the European Medicines Agency for the Treatment of Lennox-Gastaut Syndrome

Frost & Sullivan announces #FrostTalk Twitter Chat on Disruptive Technologies to Combat Depression
SANTA CLARA, Calif., March 29, 2017 /PRNewswire/ -- World Health Day, which is celebrated every year on April 7th to mark the anniversary of the founding of the World Health Organization (WHO), provides us with a unique opportunity to mobilize action around a specific health top.....


  • More Evidence of the Link Between Gum Disease and Diabetes Points Out the Systemic Importance of Good Oral Health, says Dr. Peiman Soleymani
  • Interventional Radiology Market Growing at a CAGR of 6.7% During 2016 to 2021 - ReportsnReports
  • Dr. Natalie Geary selected as "Top Pediatrician of the Year" for 2017 by the International Association of Top Professionals (IAOTP).
  • Audiology Devices Market is Expected to Reach USD 12,715.3 Mn by 2023 - Credence Research
  • Global $20.99 Billion Ablation Devices Market 2017-2023: Oncology is Holding the Largest Revenue in 2016

  • COA Completely Disagrees with Draft MedPAC Medicare Part B Recommendations
  • Two South Florida Medical Facilities Choose Air Esscentials to Implement Innovative Hospital Environmental Scenting Programs
  • Ablation Devices Global Market - Forecast to 2023 - Improving Reimbursement Scenario in Established Markets is a Key Market Driver - Research and Markets
  • BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify
  • Liquid Biopsies That Can Screen and Detect Cancer Early Winning Over Investors

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines